Therapy Animal Collars - Natural Pet Safe Animal Care - No Drugs, No Chemicals - Free Trial
Therapy Collars announces a limited-time free trial for its Therapy Animal Collars. The collars have the ability to naturally address the symptoms of allergies, fleas and ticks, old age, pain and discomfort, anxiety, excess licking and scratching...and more. All without drugs, chemicals, herbs, or magnets. http://www.therapycollars.com
Atlanta, GA (PRWEB) October 31, 2012
Therapy Animal Collars line of holographic collars and pet tags are now available for pet owners on a free trial basis. The natural, pet safe, holistic collars and pet tags are normally $19 for a month's supply but are being offered by the company for a limited time at no cost for the product.
Therapy Collars and Tags are a natural alternative and holistic alternative to drugs, chemicals, and herbs, and even magnets. They can help your pet through the use of energy information stored in the tags and collars.
There is no “placebo” effect with animals, nor psychological judgements or prejudices. Animals cannot lie so the proof of effectiveness is simply the animal's response and behavior. Pet owners report seeing changes occurring from within a few days to a few weeks, depending on the animal's symptoms.
Therapy Animal Collars is committed to supporting those organizations that provide shelter and services for animals as well as advocates of animal rights. The company will donate 10% of its profits to help these causes, such as the SF SPCA and other non-profit animal organizations. Inquiries are invited.
Veterinarians are invited to contact the company for testing their collars, at no charge.
The company's owners have been working in this industry for six years. In what is a complete reversal of the norm, the company "tested" with people first and then applied the knowledge to the pet industry. Therapy Collars is located in Atlanta, GA and can be reached at 800-PET-8171 or support(at)therapycollars(dot)com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/10/prweb10068783.htmView Comments and Join the Discussion!